☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Astrazeneca
AstraZeneca Reports Data from the P-III (WAYPOINT) Study of Tezspire (Tezepelumab) for Chronic Rhinosinusitis with Nasal Polyps
November 8, 2024
AstraZeneca’s Fasenra Receives EU Approval for Eosinophilic Granulomatosis with Polyangiitis
October 29, 2024
AstraZeneca at ERA’24: Mina Makar in a Stimulating Conversation with PharmaShots
October 28, 2024
AstraZeneca and Ionis’ Wainzua (Eplontersen) Receives the CHMP’s Positive Opinion to Treat Hereditary Transthyretin-Mediated Amylo...
October 21, 2024
AstraZeneca and Daiichi Sankyo Report the NMPA’s Conditional Approval of Enhertu to Treat Metastatic NSCLC with HER2 Mutations
October 14, 2024
PharmaShots Weekly Snapshots (October 07 – October 11, 2024)
October 11, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.